Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Oct
25
2023
Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives Sheppard, Mullin, Richter & Hampton LLP
Oct
25
2023
California Bans Several FDA-Authorized Food Additives; New York May Soon Follow ArentFox Schiff LLP
Oct
25
2023
DEA Further Extends Flexibilities for Controlled-Substance Prescribing Via Telemedicine McDermott Will & Emery
Oct
25
2023
FDA Publishes FY 2021 Pesticide Residue Report Keller and Heckman LLP
Oct
24
2023
Congress May Have a Vision for Psychedelic Regulation in the US Epstein Becker & Green, P.C.
Oct
24
2023
Stocking Naloxone in the Workplace: What Employers Need to Consider Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
24
2023
Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024 Mintz
Oct
24
2023
FDA Updates Guidance Regarding Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Devices and Drugs Nelson Mullins
Oct
24
2023
DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 Epstein Becker & Green, P.C.
Oct
24
2023
DEA Further Extends COVID-19 Telemedicine Prescribing Flexibilities through December 31, 2024 Robinson & Cole LLP
Oct
24
2023
EPA Announces Winners of the 2023 Green Chemistry Challenge Awards Bergeson & Campbell, P.C.
Oct
24
2023
FDA Seeks to Increase Regulatory Oversight of Laboratory Developed Tests ArentFox Schiff LLP
Oct
24
2023
Lawsuit Alleges Panera’s Caffeinated Lemonade Caused Death Keller and Heckman LLP
Oct
24
2023
In This Case, "Primarily" Means A Small Fraction Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
23
2023
OCR Cybersecurity Newsletter Emphasizes Significance of HIPAA Sanction Policies Mintz
Oct
23
2023
California Bans Four Federally Cleared Additives From Use in Food K&L Gates
Oct
23
2023
FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework Keller and Heckman LLP
Oct
23
2023
Safeguarding AI Innovation in Stem Cell Therapy Foley & Lardner LLP
Oct
22
2023
NNI Nanoinformatics Conference and U.S.-EU NanoEHS COR Workshop Will Be Held in November 2023 Bergeson & Campbell, P.C.
Oct
20
2023
Dirty Steel-Toe Boots, Episode 20: Marijuana in the Workplace [Podcast] Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
20
2023
APHIS Releases Revised Draft and Response to Comments on Guide for Submitting Permit Applications for Microorganisms Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Oct
19
2023
APHIS Releases Revised Guidance for Genetically Engineered Microorganism Applications Keller and Heckman LLP
Oct
18
2023
FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference Sheppard, Mullin, Richter & Hampton LLP
Oct
18
2023
Behavioral Health Law Ledger | October 2023 Greenberg Traurig, LLP
Oct
18
2023
California Attorney General Issues Enforcement Advisory Letter to Warn Companies of Responsibility to Disclose Presence of PFAS Bergeson & Campbell, P.C.
Oct
18
2023
DOJ's Consumer Protection Branch Continues Civil Enforcement Against Pharmacies, Pharmacists for Opioid Dispensing Barnes & Thornburg LLP
Oct
18
2023
OECD Tour de Table Includes Information on U.S. Developments on Human Health and Environmental Safety of Nanomaterials Bergeson & Campbell, P.C.
Oct
18
2023
FDA Issues New Enforcement Policy for Face Masks and Barrier Face Coverings ArentFox Schiff LLP
Oct
18
2023
Califf Provides Update on Front-of-Package Labeling Keller and Heckman LLP
Oct
17
2023
CPSC Signals its Regulatory Interest in PFAS Foley & Lardner LLP
Oct
17
2023
Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule Sheppard, Mullin, Richter & Hampton LLP
Oct
17
2023
Revamping Cosmetics Safety and Regulation: Updates from FDA on Regulatory Changes under MOCRA. Squire Patton Boggs (US) LLP
Oct
17
2023
United Cannabis Corporation v. Pure Hemp Collective Inc. Sheppard, Mullin, Richter & Hampton LLP
Oct
17
2023
Pharmacy Benefit Manager Reform: What’s on the Horizon? McDermott Will & Emery
Oct
17
2023
The Roundabout: AMCC Litigation and Licensing Update Bradley Arant Boult Cummings LLP
Oct
17
2023
Public Meeting on Strategies to Reduce Added Sugar Consumption Set for November Keller and Heckman LLP
Oct
17
2023
Is Medical Cannabis an Effective Treatment for Autism? A Recent US DHHS Recommendation Renews Hope for Much Needed Research Womble Bond Dickinson (US) LLP
Oct
17
2023
Recent Federal Developments, October 2023 Bergeson & Campbell, P.C.
Oct
16
2023
The Fine Print: Avoiding IP Pitfalls in Unlicensed Fonts McDermott Will & Emery
Oct
16
2023
FDA Publishes Updated Prior Notice of Imported Food Guidance Document Keller and Heckman LLP
Oct
16
2023
Rite Aid Chapter 11 Bankruptcy Filing: Just What the Doctor Ordered Stark & Stark
Oct
14
2023
Registration Opens for Nano4Earth Roundtable Discussion on Capture of GHGs Bergeson & Campbell, P.C.
Oct
13
2023
McDermottPlus Check-Up: October 13, 2023 McDermott Will & Emery
Oct
13
2023
Alive and Well: Daubert Challenges Based on an Expert’s Lack of Qualifications Phillips Lytle LLP
Oct
13
2023
Governor Signs Bill Prohibiting Any Grocery Store Purchases Without Prior Written Notice To The Attorney General Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
12
2023
FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors [Podcast] K&L Gates
Oct
12
2023
California’s Transformational Single-Use Packaging EPR Law Moves Toward Implementation Beveridge & Diamond PC
Oct
12
2023
DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 Polsinelli PC
Oct
12
2023
Cell-Cultivated Meat Is Gaining Ground Womble Bond Dickinson (US) LLP
Oct
12
2023
DEA Further Extends Telemedicine Prescribing Flexibilities Dinsmore & Shohl LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins